AgThera Inc.
Saint Paul
About AgThera Inc.
General Probiotics (GP) is a biotechnology company that discovers, develops and commercializes a new class of antimicrobial medicines for infectious diseases. GP engineers are world leaders in advanced probiotics. GP probiotics are tailored to eliminate pathogens effectively and reliably. GP has been awarded Small Business Innovative Research grants by the US National Science Foundation and the US Department of Agriculture to pursue an unparalleled, AI-enabled R&D program.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.4M
- Last round: Grant (Sep 2020)
- Website: agthera.com
- Phone: 651-503-2696
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/agthera-inc-141987 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.